A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine

Monica L. Kasting, Shannon Wilson, Brian Dixon, Stephen Downs, Amit Kulkarni, Gregory Zimet

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV.

Original languageEnglish (US)
Pages (from-to)1331-1334
Number of pages4
JournalVaccine
Volume34
Issue number11
DOIs
StatePublished - Mar 8 2016

Fingerprint

Papillomavirus Vaccines
Papillomaviridae
Health Personnel
health services
Vaccines
vaccines
Parents
Human papillomavirus 9
Interviews
interviews
Public Health
Organizations
Pediatrics
public health
Costs and Cost Analysis
adverse effects
Health

Keywords

  • Awareness
  • Education
  • Healthcare provider
  • HPV
  • Sexually transmitted infection
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine. / Kasting, Monica L.; Wilson, Shannon; Dixon, Brian; Downs, Stephen; Kulkarni, Amit; Zimet, Gregory.

In: Vaccine, Vol. 34, No. 11, 08.03.2016, p. 1331-1334.

Research output: Contribution to journalArticle

@article{8a323e0d2b214db586a3b36219001949,
title = "A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine",
abstract = "The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV.",
keywords = "Awareness, Education, Healthcare provider, HPV, Sexually transmitted infection, Vaccine",
author = "Kasting, {Monica L.} and Shannon Wilson and Brian Dixon and Stephen Downs and Amit Kulkarni and Gregory Zimet",
year = "2016",
month = "3",
day = "8",
doi = "10.1016/j.vaccine.2016.01.050",
language = "English (US)",
volume = "34",
pages = "1331--1334",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine

AU - Kasting, Monica L.

AU - Wilson, Shannon

AU - Dixon, Brian

AU - Downs, Stephen

AU - Kulkarni, Amit

AU - Zimet, Gregory

PY - 2016/3/8

Y1 - 2016/3/8

N2 - The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV.

AB - The 9-valent Human Papillomavirus (HPV) vaccine, 9vHPV, was licensed in the U.S. in December, 2014. We assessed healthcare provider (HCP) awareness of the newly approved vaccine and identified questions HCPs have about the vaccine. As part of a larger study, we used semi-structured interviews to ask 22 pediatric HCPs about their awareness of 9vHPV, questions they have about the vaccine, and questions they anticipate from patients and parents. Interviews were audio-recorded and transcribed then analyzed using inductive content analysis. Over half were aware of the vaccine but few HCPs claimed to be familiar with it. HCPs indicated several questions with common themes pertaining to efficacy, side effects, and cost. Only half of HCPs believed patients or parents would have questions. The results suggest strategies and areas for health systems and public health organizations to target in order to resolve unmet educational needs among HCPs regarding 9vHPV.

KW - Awareness

KW - Education

KW - Healthcare provider

KW - HPV

KW - Sexually transmitted infection

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84959184734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959184734&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2016.01.050

DO - 10.1016/j.vaccine.2016.01.050

M3 - Article

VL - 34

SP - 1331

EP - 1334

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 11

ER -